Evidence map›Paper›PMID 36404606›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2022

Long-Term Effect of Pancreaticoduodenectomy Combined with Revascularization for Resectable Pancreatic Carcinoma in Elderly Patients.

Jiali Yang, Zhengrong Xu, Junfeng Zhang, Yao Zheng, Jianyou Gu, Qiang Zhou, Xianxing Wang, Shixiang Guo, Hongyu Zhang, Shengkai Chen and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jiali YangDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Zhengrong XuDepartment of Surgery, Hospital of People's Liberation Army Unit 63820, Mianyang, Sichuan, China (mainland).
Junfeng ZhangDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Yao ZhengDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Jianyou GuDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Qiang ZhouDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Xianxing WangDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Shixiang GuoDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Hongyu ZhangInstitute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China (mainland).
Shengkai ChenDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
Huaizhi WangDepartment of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing, China (mainland).
First People's Hospital of Chongqing · CNArmy Medical University · CNSichuan Mianyang 404 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Pancreaticoduodenectomy combined with revascularization (PDR) is the main surgical procedure for resectable pancreatic ductal adenocarcinoma (PDAC) with venous system invasion, but this procedure is discouraged in elderly patients because of physical complexity. Our aim was to explore the differences of perioperative and survival in patients of different ages who underwent PDR. MATERIAL AND METHODS We reviewed data from PDAC patients undergoing PDR from 2007 to 2018. Patients were subdivided into 3 groups according to age: <60 years, 60-70 years, and ≥70 years. Postoperative complications and long-term survival were compared among the 3 groups. RESULTS From 626 patients, 185 had en bloc venous resection who underwent PDR (103, 55, and 27 patients from young to elderly). Increasing age was linked to a higher prevalence of ICU management (P=0.035) and more serious complications (grade ≥III, P=0.043); overall mortality was 8.1% and did not significantly differ among age-matched groups. Further, there was no difference in overall survival (OS) or progression-free survival (PFS) based on age (<60, 60-70, ≥70, median OS were 9.7, 8.4 vs 9.1 months, respectively, P=0.787; median PFS were 6.9, 6.1 vs 8.4 months, respectively, P=0.603). However, patients <60 years whose tumors invaded the superior mesenteric vascular had better survival outcomes when compared with the other 2 groups (11.5 vs 8.4, 9.1 months, P=0.049). CONCLUSIONS The results show that age should not be considered an absolute contraindication for PDR, as elderly patients can achieve the same surgical efficacy and long-term survival prognosis.

Indexed as

Pancreatic NeoplasmsPancreaticoduodenectomyAgedHumansMiddle AgedPancreatectomyPortal Vein

Identifiers

PMID36404606
PMCPMC9695170
OpenAlexW4307711152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.